Pancreatic Cancer Research

ResearcherNanjing University of Chinese MedicineActive in the last 2 years

Yongkang Zhu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0001-9123-7158; OpenAlex author ID A5049497896. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: none · 2024: none · 2025: none · 2026: 2 papers

Papers 3

  1. Ultrasound-Mediated Modulation of circRNA hsa_circ_0004870 as a Prognostic and Therapeutic Biomarker in Pancreatic Cancer. Last author DOI 10.1177/10849785251412134↗
  2. Circular RNA hsa_circ_0003472 Promotes Pancreatic Ductal Adenocarcinoma Progression and Gemcitabine Resistance Via the mir-1253/ERCC1 Axis. Co-author DOI 10.1186/s12575-026-00335-3↗
  3. Identification of Molecular Targets and Underlying Mechanisms of Xiaoji Recipe against Pancreatic Cancer Based on Network Pharmacology. Co-author DOI 10.1155/2022/4640849↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Cunbing Xia · 3 shared papers, 2022–2026 · strength 0.72
  2. Chunyang Lv · 1 shared paper, 2026 · strength 0.29
  3. Hong Zhu · 1 shared paper, 2026 · strength 0.29
  4. Hong Zhu · 1 shared paper, 2022 · strength 0.14
  5. Dong Xu · 1 shared paper, 2022 · strength 0.14
  6. Hongbao Yang · 1 shared paper, 2022 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.